AxoGen Financial Overview
AxoGen's market cap is currently $1.40B. The company's EPS TTM is $0.12; its P/E ratio is -607.76; AxoGen is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
